Cruickshank, B. M., Wasson, M. C. D., Brown, J. M., Fernando, W., Venkatesh, J., Walker, O. L., Morales‐quintanilla, F., Dahn, M. L., Dean, C. A., Vidovic, D., Vaniderstine, C., Dellaire, G., & Marcato, P. (2021). Lncrna part1 promotes proliferation and migration, is associated with cancer stem cells, and alters the mirna landscape in triple‐negative breast cancer. Cancers, 13(11), 文章 2644. https://doi.org/10.3390/cancers13112644
Lncrna part1 promotes proliferation and migration, is associated with cancer stem cells, and alters the mirna landscape in triple‐negative breast cancer. / Cruickshank, Brianne M.; Wasson, Marie Claire D.; Brown, Justin M. 等.
在:
Cancers, 卷 13, 号码 11, 2644, 01.06.2021.
科研成果: 期刊稿件 › 文章 › 同行评审
Cruickshank, BM, Wasson, MCD, Brown, JM, Fernando, W, Venkatesh, J, Walker, OL, Morales‐quintanilla, F, Dahn, ML, Dean, CA, Vidovic, D, Vaniderstine, C, Dellaire, G & Marcato, P 2021, 'Lncrna part1 promotes proliferation and migration, is associated with cancer stem cells, and alters the mirna landscape in triple‐negative breast cancer', Cancers, 卷 13, 号码 11, 2644. https://doi.org/10.3390/cancers13112644
Cruickshank BM, Wasson MCD, Brown JM, Fernando W, Venkatesh J, Walker OL 等. Lncrna part1 promotes proliferation and migration, is associated with cancer stem cells, and alters the mirna landscape in triple‐negative breast cancer. Cancers. 2021 6月 1;13(11):2644. doi: 10.3390/cancers13112644
Cruickshank, Brianne M. ; Wasson, Marie Claire D. ; Brown, Justin M. 等. / Lncrna part1 promotes proliferation and migration, is associated with cancer stem cells, and alters the mirna landscape in triple‐negative breast cancer. 在: Cancers. 2021 ; 卷 13, 号码 11.
@article{cb33cfa73c39404da4d4330428edab9b,
title = "Lncrna part1 promotes proliferation and migration, is associated with cancer stem cells, and alters the mirna landscape in triple‐negative breast cancer",
author = "Cruickshank, {Brianne M.} and Wasson, {Marie Claire D.} and Brown, {Justin M.} and Wasundara Fernando and Jaganathan Venkatesh and Walker, {Olivia L.} and Fiorella Morales‐quintanilla and Dahn, {Margaret L.} and Dean, {Cheryl A.} and Dejan Vidovic and Carter Vaniderstine and Graham Dellaire and Paola Marcato",
note = "Funding Information: Acknowledgments: P.M. and G.D. are Senior Scientists of the Beatrice Hunter Cancer Research In‐ stitute (BHCRI). B.M.C., M.L.D., and were supported by Nova Scotia Research and Innovation Grad‐ uate Scholarships and Killam Laureate scholarships. M.L.D. was also supported by CGS‐D award from the CIHR. B.M.C. and D.V. were also supported by a Master{\textquoteright}s award from the CIHR. M.‐ C.D.W., J.M.B., O.L.W. are partly supported by Genomics in Medicine scholarships from the Dal‐ housie Medical Research Foundation (DMRF), Cancer Research Training Program (CRTP) scholar‐ ships funded through the BHCRI and the Terry Fox Research Institute, and Scotia Scholars Awards funded through Research Nova Scotia. M.‐C.D.W. and O.L.W. are also supported by scholarship from Dalhousie University{\textquoteright}s Faculty of Medicine. O.L.W. is also supported by a Nova Scotia Grad‐ uate Scholarship. J.V. is supported in part by a postdoctoral fellowship in breast cancer research administered by the DMRF. C.V. was supported by a Scotia Scholars Award funded through the Nova Scotia Health Research Foundation. The PDX‐AIM Core of Baylor College of Medicine that supplied the PDX used in this study is supported by institutional funding from both the Advanced Technology Cores and the Dan L. Duncan Cancer Center (P30 Cancer Center Support Grant NCI‐ CA125123). It is also supported by a Core Facility grant from the Cancer Prevention and Research Institute of Texas (CPRIT Core Facilities Support Grant RP170691). The graphical abstract was cre‐ ated with BioRender.com (accessed on 12 May 2021). Funding Information: Funding: This research was funded by the Canadian Institutes of Health Research (CIHR, PJT 162313). Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2021",
month = jun,
day = "1",
doi = "10.3390/cancers13112644",
language = "English",
volume = "13",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "11",
}
TY - JOUR
T1 - Lncrna part1 promotes proliferation and migration, is associated with cancer stem cells, and alters the mirna landscape in triple‐negative breast cancer
AU - Cruickshank, Brianne M.
AU - Wasson, Marie Claire D.
AU - Brown, Justin M.
AU - Fernando, Wasundara
AU - Venkatesh, Jaganathan
AU - Walker, Olivia L.
AU - Morales‐quintanilla, Fiorella
AU - Dahn, Margaret L.
AU - Dean, Cheryl A.
AU - Vidovic, Dejan
AU - Vaniderstine, Carter
AU - Dellaire, Graham
AU - Marcato, Paola
N1 - Funding Information:
Acknowledgments: P.M. and G.D. are Senior Scientists of the Beatrice Hunter Cancer Research In‐ stitute (BHCRI). B.M.C., M.L.D., and were supported by Nova Scotia Research and Innovation Grad‐ uate Scholarships and Killam Laureate scholarships. M.L.D. was also supported by CGS‐D award from the CIHR. B.M.C. and D.V. were also supported by a Master’s award from the CIHR. M.‐ C.D.W., J.M.B., O.L.W. are partly supported by Genomics in Medicine scholarships from the Dal‐ housie Medical Research Foundation (DMRF), Cancer Research Training Program (CRTP) scholar‐ ships funded through the BHCRI and the Terry Fox Research Institute, and Scotia Scholars Awards funded through Research Nova Scotia. M.‐C.D.W. and O.L.W. are also supported by scholarship from Dalhousie University’s Faculty of Medicine. O.L.W. is also supported by a Nova Scotia Grad‐ uate Scholarship. J.V. is supported in part by a postdoctoral fellowship in breast cancer research administered by the DMRF. C.V. was supported by a Scotia Scholars Award funded through the Nova Scotia Health Research Foundation. The PDX‐AIM Core of Baylor College of Medicine that supplied the PDX used in this study is supported by institutional funding from both the Advanced Technology Cores and the Dan L. Duncan Cancer Center (P30 Cancer Center Support Grant NCI‐ CA125123). It is also supported by a Core Facility grant from the Cancer Prevention and Research Institute of Texas (CPRIT Core Facilities Support Grant RP170691). The graphical abstract was cre‐ ated with BioRender.com (accessed on 12 May 2021).
Funding Information:
Funding: This research was funded by the Canadian Institutes of Health Research (CIHR, PJT 162313).
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/6/1
Y1 - 2021/6/1
UR - http://www.scopus.com/inward/record.url?scp=85106585174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106585174&partnerID=8YFLogxK
U2 - 10.3390/cancers13112644
DO - 10.3390/cancers13112644
M3 - Article
AN - SCOPUS:85106585174
SN - 2072-6694
VL - 13
JO - Cancers
JF - Cancers
IS - 11
M1 - 2644
ER -